They linked aspirin to a carrier consisting of a fragment of protein that can transport aspirin directly to damaged parts of blood vessels where clots form
A new form of aspirin to overcome ‘aspirin resistance’
ACS Nano
Scientists are reporting development of a new form of aspirin — taken daily by about 60 million people in the United States alone to reduce the risk of heart attack and stroke — that could extend aspirin’s benefits to people who may not respond to the drug. Their advance toward coping with “aspirin resistance” appears in the journal ACS Nano.
